News - Page 280

TLDR: Naver’s Webtoon Entertainment files for US IPO with financial heavyweights leading the offering Hello Health Group secures investment from 5i Ventures to support growth in Asia Naver’s Webtoon Entertainment, a subsidiary

TLDR: Blackstone has secured the top spot on the PEI 300 ranking, raising nearly $124 billion over the past five years. Key Points: Blackstone holds the top spot on the PEI 300

TLDR: Key Points: Bcas, a student finance edtech platform, has raised €17 million in funding. The funding will be used to support international expansion plans and provide financing for students. In a

TLDR: Banc of California launches Build@Banc program targeting startups in early stages The program aims to support entrepreneurs from initial investments to IPOs Banc of California recently introduced a new service called

TLDR: Iyris, a Saudi Arabia-based AgriClimate technology company, raised $16M in Series A funding. The funding round was led by Ecosystem Integrity Fund and included participation from several other venture capital firms.

TLDR: – Venture capital firms Jekara and Tidal Ventures are investing in Queensland tech start-ups. – Jekara is focusing on finding the next global energy disruptor in Queensland, while Tidal Ventures is

TLDR: – The Lumber Manufactory raised $4.1 million in seed funding round – Company aims to build sustainable sawmills with next-generation technology The Lumber Manufactory has raised $4.1 million from unidentified investors

TLDR: Most startup companies are not started in Silicon Valley, contrary to popular belief. The average age of a typical founder is 42, and most startups never raise venture capital. In the

TLDR: Key Points: Investors are showing renewed interest in European tech start-ups. This enthusiasm is reflected in increased funding rounds and valuations. Investors in Europe are reviving their enthusiasm for tech start-ups,

TLDR: 2Flo Ventures has announced the addition of renowned life sciences executive Dr. Charlotte Jones-Burton as a partner. Dr. Jones-Burton brings nearly two decades of experience in the biopharmaceutical industry and will